Anti-Microbial Savior BioteQ Co., Ltd. (6864) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Anti-Microbial Savior BioteQ Co., Ltd. (6864:TWSE), powered by AI.

Current Price
$48.95
Sector
Healthcare
What is the Anti-Microbial Savior BioteQ Co., Ltd. stock price forecast?

Anti-Microbial Savior BioteQ Co., Ltd. is currently trading at $48.95. View real-time AI analysis on Alpha Lenz.

What is Anti-Microbial Savior BioteQ Co., Ltd. insider trading activity?

View the latest insider trading data for Anti-Microbial Savior BioteQ Co., Ltd. on Alpha Lenz.

What is Anti-Microbial Savior BioteQ Co., Ltd.'s P/E ratio?

View Anti-Microbial Savior BioteQ Co., Ltd.'s valuation metrics on Alpha Lenz.

Anti-Microbial Savior BioteQ Co., Ltd.

TWSE · 6864
NT$48.95-0.80(-1.61%)
Ask about Anti-Microbial Savior BioteQ Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Anti-Microbial Savior BioteQ Co., Ltd.'s ROE is -25.0%. Explore profitability and growth together.

Ask for details

Company Overview

Anti-Microbial Savior BioteQ Co., Ltd. is a biotechnology company specializing in the research and development of innovative pharmaceutical products, established in 2018 and headquartered in Kaohsiung, Taiwan. Its primary focus is on creating advanced antimicrobial solutions, including new classes of antibiotics designed to combat drug-resistant bacteria and viruses. The company is notable for its development and patenting of medicinal fungi and biomedical implants, as well as pioneering products such as artificial wound dressings (notably SIPSIPT), the antibacterial drug FORMOSA-1117, and the antiviral drug YUAN-03. These products are engineered to effectively manage challenging conditions like wounds with high exudate, overcome antibiotic-resistant bacterial infections, and inhibit viral replication at the cellular level. Anti-Microbial Savior BioteQ Co., Ltd. plays a significant role in the healthcare sector, contributing to the fight against the mounting threat of antimicrobial resistance and supporting advancements in global biomedical research and patient care through technology-driven innovation.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$706.00KRevenue
0.00Shares Out
0Employees

Margins

46.18%Gross
-11677.48%EBITDA
-13595.61%Operating
-13257.37%Pre-Tax
-13257.37%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

-36.03%Rev 3Yr
57.43%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-24.36%ROA
-25.03%ROE
-24.35%ROIC

Financial Health

NT$466.22MCash & Cash Equivalents
NT$-456.30MNet Debt
1.94%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Anti-Microbial Savior BioteQ Co., Ltd. (ticker: 6864) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 48.95 with a P/E ratio of -x and P/B of -x.

ROE is -25.03% and operating margin is -13595.61%. Annual revenue is $706,000.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Anti-Microbial Savior BioteQ Co., Ltd. (6864) Stock Forecast 2026 $48.95 — Price, Financials & Analyst Targets | Alpha Lenz